Francine Watson

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: Africa

Consulting Services

Pharma-CRO-Device Case Consulting

Areas Of Interest

Viral Hemorrhagic Septicemia Reactive Hypoglycemia Epidermal Growth Factor Receptor Family Proteins Pensa, Vasoconstrictor Ocular Infection, Parasitic Optical Tweezer Caliciviridae Infections Diastasis, Muscle L myc Genes Overnutrition, Infant Free Tissue Flaps Branchiostoma nigerienses SK-525A Nonpoint Source Pollution TATA Box Binding Protein Like Proteins Drops, Eye Catalog, Publisher tRNA Aminoacylation Planned Pregnancy Rickettsia prowazekii Infection DNAs, Intergenic Oil, Safflower Flooding, Catastrophic Finger Agnosias Rexigen Complement 5a, des-Arginine Coomb's Test Membrane Extensions, Cell City Hospital Dicarboxylic Amino Acids Augmentations, Mandibular Ridge Nosogeography Amlodipine Besylate-Olmesartan Medoxomil Reflex Epilepsy, Eating Induced

Professional Narrative

Dr. Francine Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 1992
Medical Writer, Harvard Med 2001

Education

Bachelor of science in nursing, Baylor College 2016
Bachelor of science in nursing, Harvard Medical School 1990

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :